Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB.

Slides:

Advertisements

Similar presentations

Kevin S. Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Associate Professor of Surgery Harvard.

Advertisements

Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast.

Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Harvard Medical School Date 06/01/2007.

Volume 34, Pages (August 2017) Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer – Results from the.

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer Victor E. Chen, BS, Erin.

Frances A Shepherd, MD, Rafael Rosell, MD Journal of Thoracic Oncology

The impact of ipsilateral breast tumor recurrence on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy C.

The Hartford Consensus: Survey of the Public and Healthcare Professionals on Active Shooter Events in Hospitals Lenworth M. Jacobs, MD, MPH, FACS, Karyl.

Trend in Volume of Urologic Prosthetic Surgery after Initiation of Prostate Cancer Survivorship Program Alison M. Rasper, MD, Kara E. McAbee, MD, Marc.

Neoadjuvant Chemotherapy for Breast Cancer Increases the Rate of Breast Conservation: Results from the National Cancer Database Brigid K. Killelea, MD,

Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage.

Simple Suturing Technique for Umbilical Dimple Wound after Single-Incision Laparoscopic Surgery Yoichi Matsui, MD, PhD, Sohei Satoi, MD, PhD, FACS, Satoshi.

Procedure-Specific Trends in Surgical Outcomes

Exploring the Relationship Between Stereotype Perception and Residents' Well-Being Arghavan Salles, MD, PhD, Claudia M. Mueller, PhD, MD, FACS, Geoffrey.

Preoperative Standard Oral Nutrition Supplements vs Immunonutrition: Results of a Systematic Review and Meta-Analysis Refaat A. Hegazi, MD, PhD, MPH,

Simple Suturing Technique for Umbilical Dimple Wound after Single-Incision Laparoscopic Surgery Yoichi Matsui, MD, PhD, Sohei Satoi, MD, PhD, FACS, Satoshi.

Introduction of Mechanical Sphincter Augmentation for Gastroesophageal Reflux Disease into Practice: Early Clinical Outcomes and Keys to Successful Adoption

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901 Stephen L. Graziano,

Validation of New Readmission Data in the American College of Surgeons National Surgical Quality Improvement Program Morgan M. Sellers, BA, Ryan P. Merkow,

Are Surgeons Being Paid Fairly by Medicaid

A Patient-Centered Early Warning System to Prevent Readmission after Colorectal Surgery: A National Consensus Using the Delphi Method Linda T. Li, MD,

Perceived Complexity of Various Liver Resections: Results of a Survey of Experts with Development of a Complexity Score and Classification Major K. Lee,

Nonclinical Factors Associated with 30-Day Mortality after Lung Cancer Resection: An Analysis of 215,000 Patients Using the National Cancer Data Base

Creating Individual Surgeon Performance Assessments in a Statewide Hospital Surgical Quality Improvement Collaborative Christopher M. Quinn, MS, Karl.

How Well Informed Do Patients Feel about Their Breast Cancer Surgery Options? Findings from a Nationwide Survey of Women after Lumpectomy and/or Mastectomy

Journal of the American College of Surgeons

Cost Effectiveness of Mesh Prophylaxis to Prevent Parastomal Hernia in Patients Undergoing Permanent Colostomy for Rectal Cancer Lawrence Lee, MD, MSc,

Gastric Perforation Associated with Bilateral Inguinal Hernias

How should we treat air leaks?

Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection Shalini Garg, MD,

Maureen V. Hill, MD, Ryland S. Stucke, MD, Sarah E

Latest information for the thoracic surgeon from the Annual Meeting of the American Society of Clinical Oncology Sarita Dubey, MD, Giorgio Scagliotti,

Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making Neal Bhutiani, MD, Michael E. Egger, MD,

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Changing Surgical Trends in Young Patients with Early Stage Breast Cancer, 2003 to 2010: A Report from the National Cancer Data Base Catherine E. Pesce,

Epidermal Growth Factor Receptor, C-kit, and Her2/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004.

Yang Zhang, MD, Haiquan Chen, MD, PhD

Impact on Disease-Free Survival of Adjuvant Erlotinib or Gefitinib in Patients with Resected Lung Adenocarcinomas that Harbor EGFR Mutations Yelena Y.

Lisa M. Knowlton, MD, MPH, FRCSC, Arden M

Thomas J. Birdas, MD, MBA, FACS, Grace F

Erratum Journal of Thoracic Oncology

Trend in Volume of Urologic Prosthetic Surgery after Initiation of Prostate Cancer Survivorship Program Alison M. Rasper, MD, Kara E. McAbee, MD, Marc.

David J. Leehey, MD, Tony Casini, MS, Donald Massey, DO

Richard C. Frazee, MD, FACS, Stephen W. Abernathy, MD, FACS, Daniel C

Assessing Learning During Morbidity and Mortality Conference with a Real-time Response System Ira L. Leeds, MD, Sandra DiBrito, MD, Christian Jones,

Exploring the Relationship Between Stereotype Perception and Residents' Well-Being Arghavan Salles, MD, PhD, Claudia M. Mueller, PhD, MD, FACS, Geoffrey.

Significant Variation in Surgical Supply Cost Secondary to Surgeon Preference for Laparoscopic Cholecystectomy Michelle C. Nguyen, MD, Matthew J. Luzum,

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Timing of Complications and Length of Stay after Rectal Cancer Surgery

Adjuvant Chemotherapy Is Associated with Improved Survival after Esophagectomy without Induction Therapy for Node-Positive Adenocarcinoma Paul J. Speicher,

David J. Hall, MD, Kevin R. Olsen, MD, Juan C. Mira, MD, Patrick W

Use of Endoscopic Ultrasound in the Preoperative Staging of Gastric Cancer: A Multi- Institutional Study of the US Gastric Cancer Collaborative Gaya Spolverato,

Phase II Trial of Paclitaxel–Topotecan–Etoposide Followed by Consolidation Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: CALGB 30002 Antonius.

RTOG 0017: A Phase I Trial of Concurrent Gemcitabine/Carboplatin or Gemcitabine/Paclitaxel and Radiation Therapy (“Ping-Pong Trial”) Followed By Adjuvant.

International Thymic Malignancies Interest Group: A Way Forward

Longterm survival after extended resections in patients with gallbladder cancer Anu Behari, MS, Sadiq S Sikora, MS, FACS, Gajanan D Wagholikar, MSMCh,

Excision with Split-Thickness Skin Graft and Negative-Pressure Therapy for the Treatment of Hidradenitis: A Potential Cure? Robert T. Nevitt, MD, Lauren.

Stephen R. Broderick, MD, MPHS, Aalok P. Patel, BS, BA, Traves D

Journal of the American College of Surgeons

Blake Cady, MD, Thomas Miner, MD, Abraham Morgentaler, MD

Trauma: Still the Cornerstone of Acute Care Surgery Specialty

How Well Informed Do Patients Feel about Their Breast Cancer Surgery Options? Findings from a Nationwide Survey of Women after Lumpectomy and/or Mastectomy

Impact of Immunotherapy after Resection of Pancreatic Cancer

Induction Therapy For Locally Advanced Thymoma

A Randomized, Phase II Trial of Two Dose Levels of Temsirolimus (CCI-779) in Patients with Extensive-Stage Small-Cell Lung Cancer Who Have Responding.

Rogerio C. Lilenbaum, MD, John Cashy, PhD, Thomas A

Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.

A Review of First-Line Treatment for Small-cell Lung Cancer

Ruchi Thanawala, MD, Jonathan L. Jesneck, PhD, Gladys L

Presentation transcript:

Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative) David W. Ollila, MD, FACS, Constance T. Cirrincione, MS, Donald A. Berry, PhD, Lisa A. Carey, MD, William M. Sikov, MD, Clifford A. Hudis, MD, Eric P. Winer, MD, Mehra Golshan, MD, FACS Journal of the American College of Surgeons Volume 224, Issue 4, Pages 688-694 (April 2017) DOI: 10.1016/j.jamcollsurg.2016.12.036 Copyright © 2017 American College of Surgeons Terms and Conditions

Figure 1 C40601 schema. AC, adjuvant chemotherapy; BCT, breast-conserving therapy; HER2, human epidermal growth factor receptor-2; T, weekly paclitaxel; H, trastuzumab; L, lapatinib. ∗Excluding clinical T4d tumors. Journal of the American College of Surgeons 2017 224, 688-694DOI: (10.1016/j.jamcollsurg.2016.12.036) Copyright © 2017 American College of Surgeons Terms and Conditions

Figure 2 C40603 Schema. AUC, area under the curve; BCT, breast-conserving therapy; ddAC, dose-dense doxorubicin and cyclophosphamide. ∗Treatment decision made at the discretion of breast oncology team. Journal of the American College of Surgeons 2017 224, 688-694DOI: (10.1016/j.jamcollsurg.2016.12.036) Copyright © 2017 American College of Surgeons Terms and Conditions